ProfoundBio discovers the joys of having a wealthy owner
Key Takeaways:
Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion
The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months
By Doug Young
